Buy Harte-Hanks (HHS) and TARO Pharmaceuticals (TARO)

In the November issue of Roadrunner Stocks, two new BUY recommendations and two SELL recommendations have been issued.

1. The Value Portfolio is adding marketing technology services company Harte-Hanks (HHS) and selling auto-equipment supplier Lydall (LDL).

2. The Momentum Portfolio is adding generic skin drug maker TARO Pharmaceuticals (TARO) and selling oil and natural gas producer Matador Resources (MTDR).

Read More . . .





Stock Talk

Add New Comments

You must be logged in to post to Stock Talk OR create an account